The medical device firm reported Q1 2026 net revenue of $16.7 million, up 65% year-over-year, prompting raised guidance.
Shoulder Innovations raised its 2026 net revenue forecast to $65M-$68M after posting Q1 2026 revenue of $16.7 million. The figure marks a 65% increase from the same period last year and a 16% sequential rise.
The company also reported a Q1 gross margin of 77.7%, reflecting strong operational performance. Prior guidance was not disclosed, but the update follows a period of accelerated growth.
No immediate market reaction was detailed in the earnings call summary.